
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Nutr.
Sec. Nutritional Epidemiology
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1526053
This article is part of the Research Topic The First 1000 Days: Window of Opportunity for Child Health and Development View all 17 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: Folic acid has been associated with fetal development, especially in fetal immunity.Therefore, limited evidence regarding the effects of different folic acid supplementation of hepatitis B surface antigen (HBsAg) positive mothers in infants innate immunity. Herein, this study aimed to explore the association between folic acid supplementation and the innate immunity of neonates and the immunological efficacy of hepatitis B vaccine (hepB), which may provide insights that could inform pre-pregnancy health management in HBsAg-positive mothers. Materials and methods : It is an ambispective cohort study with 293 pairs of HBsAg-positive mothers-offspring in Taiyuan, Shanxi Province, China. Mothers were classified into three groups according to the time of starting folic acid supplementation, non-supplementation group, pre-pregnancy group and post-pregnancy supplementation group. Immunological indexes such as immune cells proportion and innate immune mediators in cord blood and anti-HBs in infants were measured. Differences in immunological indexes were analyzed by a One-Way ANOVA test. Univariate and multivariate analyses were performed for factors associated with abnormal immunological indexes and potential confounders were adjusted. Results: The preconception folic acid group showed a significantly higher expression levels of STING (P=0.005) and pNF-κB (P=0.010) in cord blood along with higher anti-HBs titres (P=0.006), when compared to both non-supplementation group and post-pregnancy supplementation group. Higher anti-HBs levels indicate a stronger immune response to hepB and may enhance protection against HBV infection during early life. Infants in the high pNF-κB expression group exhibited a significantly elevated seropositive rate of hepB compared to those in the low pNF-κB expression group (P=0.037). There were no mediation effects and no moderation effects in this study, potentially due to the direct influence of folic acid supplementation on immune responses or the limited sample size. . Discussion : In conclusion, our findings demonstrate that preconception folic acid supplementation may enhance BV vaccine responsiveness in infants of HBsAg-positive mothers.Meanwhile, high pNF-κB expression in cord blood can increase seropositive rates in infants. This discovery has significant public health implications, as it may provide a simple and accessible intervention to improve vaccination outcomes and reduce HBV transmission in endemic regions.
Keywords: anti-HBs1, cohort study2, Folic acid3, HBsAg-positive mothers4, Innate immunity5
Received: 11 Nov 2024; Accepted: 24 Mar 2025.
Copyright: © 2025 Lian, Men, Xu, Li, Li, Wang, Yao, Li, Qu, Feng and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yongliang Feng, School of Public Health, Shanxi Medical University, Taiyuan, 030001, Shanxi Province, China
Suping Wang, School of Public Health, Shanxi Medical University, Taiyuan, 030001, Shanxi Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.